Home » Stocks » JAN

JanOne Inc. (JAN)

Stock Price: $5.63 USD -0.03 (-0.44%)
Updated Jan 22, 2021 2:34 PM EST - Market open
Market Cap 10.45M
Revenue (ttm) 36.14M
Net Income (ttm) -12.14M
Shares Out 1.87M
EPS (ttm) -3.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $5.63
Previous Close $5.65
Change ($) -0.03
Change (%) -0.44%
Day's Open 5.60
Day's Range 5.45 - 5.73
Day's Volume 26,386
52-Week Range 2.05 - 7.79

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 4 months ago

LAS VEGAS, Sept. 22, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relievi...

PRNewsWire - 4 months ago

LAS VEGAS, Sept. 16, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 4 months ago

LAS VEGAS, Aug. 28, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 4 months ago

LAS VEGAS, Aug. 26, 2020 /PRNewswire/ -- JanOne Inc.

Seeking Alpha - 4 months ago

JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript

PRNewsWire - 5 months ago

LAS VEGAS, Aug. 21, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 5 months ago

LAS VEGAS, Aug. 19, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 5 months ago

LAS VEGAS, Aug. 11, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 5 months ago

LAS VEGAS, Aug. 6, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 5 months ago

LAS VEGAS, Aug. 4, 2020 /PRNewswire/ -- JanOne Inc.

PRNewsWire - 5 months ago

LAS VEGAS, July 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with...

PRNewsWire - 6 months ago

LAS VEGAS, July 8, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with ...

PRNewsWire - 6 months ago

LAS VEGAS, June 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with...

PRNewsWire - 6 months ago

LAS VEGAS, June 25, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain r...

About JAN

JanOne develops treatments for conditions that cause severe pain. The company, through its non-addictive pain-relieving drugs, focuses on reduction for need of opioid prescriptions to treat disease associated pain that can lead to opioid abuse. Its lead candidate JAN101 provides slow-release formulation of sodium nitrite therapeutic for treatment of peripheral artery disease (PAD). The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976... [Read more...]

Industry
Waste Management
Founded
1976
CEO
Tony Isaac
Employees
199
Stock Exchange
NASDAQ
Ticker Symbol
JAN
Full Company Profile

Financial Performance

In 2019, JanOne's revenue was $35.10 million, a decrease of -4.61% compared to the previous year's $36.79 million. Losses were -$11.96 million, 113.3% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for JanOne is 4.00, which is a decrease of -28.89% from the latest price.

Price Target
$4.00
(-28.89% downside)